💊New FDA Medicine Approval ⚕️Medicine: Fruzaqla ® 👉active ingredient: fruquintinib ✔️Indications To treat refractory, metastatic colorectal cancer. ⚙️Mechanism of Action Fruquintinib inhibits VEGF-induced phosphorylation of VEGFRs 1, 2, and 3. This inhibits the migration, proliferation and survival of endothelial cells, microvessel formation, hence inhibition of tumor cell proliferation, leading to tumor cell death.
The post Fruzaqla (fruquintinib): Use, Dose, Side Effects appeared first on Nigerian Health Blog.
​ 💊New FDA Medicine Approval ⚕️Medicine: Fruzaqla ® 👉active ingredient: fruquintinib ✔️Indications To treat refractory, metastatic colorectal cancer. ⚙️Mechanism of Action Fruquintinib inhibits VEGF-induced phosphorylation of VEGFRs 1, 2, and 3. This inhibits the migration, proliferation and survival of endothelial cells, microvessel formation, hence inhibition of tumor cell proliferation, leading to tumor cell death.
The post Fruzaqla (fruquintinib): Use, Dose, Side Effects appeared first on Nigerian Health Blog.Â
